European Organisation For Research And Treatment Of Cancer - Eortc

This large, late-stage trial is testing if combining a standard hormone-blocking pill (enzalutamide) with a bone-targeted radiation treatment (Ra223) works better than the pill alone for men whose prostate cancer has spread to their bones and is no longer responding to standard h…

This study is testing whether a new oral pill called darolutamide can control prostate cancer as well as standard hormone injections. It will compare the two treatments in about 250 men who have not yet received hormone therapy. The main goal is to see if the pill can lower PSA l…

This study is testing the best way to use the drug osimertinib for advanced lung cancer with a specific genetic change (EGFR mutation). It compares starting osimertinib right away versus starting another drug first and switching to osimertinib later, guided by a blood test that l…